Joel E. Lavine

Active 1990–2022

77
Papers
37,791
Citations
71
h-index
77
i10-index

Citations

Citations per year for Joel E. Lavine1952: 1 citations1990: 5 citations1991: 9 citations1992: 6 citations1993: 7 citations1994: 9 citations1995: 5 citations1996: 13 citations1997: 14 citations1998: 10 citations1999: 16 citations2000: 15 citations2001: 19 citations2002: 29 citations2003: 27 citations2004: 40 citations2005: 59 citations2006: 57 citations2007: 90 citations2008: 104 citations2009: 176 citations2010: 188 citations2011: 257 citations2012: 280 citations2013: 400 citations2014: 407 citations2015: 532 citations2016: 586 citations2017: 480 citations2018: 503 citations2019: 1,635 citations2020: 1,961 citations2021: 1,969 citations2022: 1,514 citations2023: 1,113 citations2024: 1,519 citations2025: 698 citations2026: 18 citations1953–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,691 citing papers, 24% of this breakdownChina: 2,006 citing papers, 13.1% of this breakdownItaly: 950 citing papers, 6.2% of this breakdownUnited Kingdom: 898 citing papers, 5.8% of this breakdownGermany: 621 citing papers, 4% of this breakdownJapan: 525 citing papers, 3.4% of this breakdownSouth Korea: 474 citing papers, 3.1% of this breakdownFrance: 430 citing papers, 2.8% of this breakdownSpain: 423 citing papers, 2.8% of this breakdownCanada: 379 citing papers, 2.5% of this breakdownAustralia: 342 citing papers, 2.2% of this breakdownIndia: 276 citing papers, 1.8% of this breakdown
0%24%Other 28.3%

Fields

  • Medicine87.4%
  • Biochemistry, Genetics and Molecular Biology7.9%
  • Nursing0.8%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Immunology and Microbiology0.6%
  • Environmental Science0.5%
  • Other2.1%

Topics

  • Liver Disease Diagnosis and Treatment26.3%
  • Diet, Metabolism, and Disease7.1%
  • Liver Disease and Transplantation6.5%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.8%
  • Liver Diseases and Immunity3.1%
  • Alcohol Consumption and Health Effects3%
  • Other50.2%

Coauthors

All papers

Open in search
  1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

    Authors: , , , , , , , , - Hepatology 2017 cited by 7,293

  2. Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 3,297

  3. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2014 cited by 2,185

  4. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

    Authors: , , , , , , , - Hepatology 2012 cited by 3,823

  5. Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents

    Authors: - JAMA 2011 cited by 1,088

  6. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

    Authors: , , , , , , , - Gastroenterology 2012 cited by 1,774

  7. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA Network Open 2019 cited by 367

  8. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2019 cited by 296

  9. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis

    Authors: , , , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 242

  10. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kumar Sandrasegaran, Raj Vuppalanchi, Elizabeth M. Brunt, Theresa Cattoor, Danielle Carpenter, Janet Freebersyser, Debra King, Jinping Lai, Brent A. Neuschwander‐Tetri, Joan Siegner, Susan L. Stewart, Susan Torretta, Kristina Wriston, Maria Cardona Gonzalez, Jodie Davila, Manan Jhaveri, Kris V. Kowdley, Nizar A. Mukhtar, Erik Ness, Michelle Poitevin, Brook A. Quist, Sherilynn Soo, Brandon Ang, Cynthia Behling, Archana Bhatt, Rohit Loomba, Michael S. Middleton, Claude B. Sirlin, Maheen F. Akhter, Nathan M. Bass, Danielle Brandman, Ryan M. Gill, Bilal Hameed, Jacqueline Maher, Norah A. Terrault, Ashley Ungermann, Matthew M. Yeh, Sherry Boyett, Melissa J. Contos, S. Kirwin, Velimir A. Luketic, Puneet Puri, Arun J. Sanyal, Jolene Schlosser, Mohammad Shadab Siddiqui, Leslie Yost-Schomer, Elizabeth M. Brunt, Kathryn J. Fowler, David E. Kleiner, Edward Doo, Sherry Hall, Jay H. Hoofnagle, Jessica J. Lee, Patricia R. Robuck, Averell H. Sherker, Rebecca Torrance, Patricia Belt, Jeanne M. Clark, J.A. Dodge, Michele Donithan, Erin Hallinan, Milana Isaacson, Mariana Lazo, Jill Meinert, Laura Miriel, Jacqueline Smith, Michael L. Smith, Alice Sternberg, James Tonascia, Mark L. Van Natta and 4 more - Clinical Gastroenterology and Hepatology 2019 cited by 268

  11. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2017 cited by 427

  12. Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 123

  13. Prevalence of Fatty Liver in Children and Adolescents

    Authors: , , , , , - PEDIATRICS 2006 cited by 1,477

  14. Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2022 cited by 97

  15. Endpoints and clinical trial design for nonalcoholic steatohepatitis

    Authors: , , , , , , , - Hepatology 2011 cited by 757

  16. Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis

    Authors: , , , , , , , , , , , , - Radiology 2013 cited by 526

  17. Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Pediatrics 2006 cited by 860

  18. Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kimberlee Bernstein, Stephanie DeVore, Rohit Kohli, Kathleen D. Lake, Daniel J. Podberesky, Alexander J. Towbin, Joel E. Lavine, Ali Mencin, Elena Reynoso, Adina Alazraki, Rebecca Cleeton, María Cordero, Albert Hernandez, Saul J. Karpen, Jessica Cruz Muños, Nicholas Raviele, Miriam B. Vos, Molly Bozic, Laura Carr, Oscar W. Cummings, Kathryn E. Harlow, Ann Klipsch, Jean P. Molleston, Emily Ragozzino, Girish S. Rao, Kimberly Kafka, Ann Scheimann, Mark Fishbein, Joy Ito, Saeed Mohammad, Peter F. Whitington, Sarah E. Barlow, Elizabeth M. Brunt, Danielle Carpenter, Theresa Cattoor, Jose Derdoy, Janet Freebersyser, Ajay K. Jain, Debra King, Jinping Lai, Joan Siegner, Susan D. Stewart, Susan Torretta, Kristina Wriston, Jorge Angeles, Jennifer Arin, Cynthia Behling, Craig Bross, Carissa Carrier, Jennifer Collins, Diana De La Pena, Janis Durelle, Mary Catherine Huckaby, Joel E. Lavine, Michael S. Middleton, Kimberly P. Newton, Jeffrey B. Schwimmer, Claude B. Sirlin, Patricia Ugalde‐Nicalo, Jesse Courtier, Ryan M. Gill, Camille Langlois, Emily R. Perito, Philip Rosenthal, Patrika Tsai, Niviann Blondet, Kara Cooper, Karen F. Murray, Randolph K. Otto, Matthew M. Yeh and 28 more - Gastroenterology 2020 cited by 106

  19. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2017 cited by 361

  20. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease

    Authors: , , , , , , , , , , - Hepatology 2016 cited by 195

  21. Multicenter Validation of Association Between Decline in MRI‐PDFF and Histologic Response in NASH

    Authors: , , , , , , , , , , , , , , - Hepatology 2020 cited by 143

  22. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Dabbas, Déirdre Kelly, Valério Nobili, Connor A. Emdin, Madison Fairey, Glenn S. Gerhard, Guðný Eiríksdóttir, Melissa E. Garcia, Vilmundur Guðnason, Tamara B. Harris, Lauren J. Kim, Lenore J. Launer, Michael A. Nalls, Albert V. Smith, Jeanne M. Clark, Rubén Hernáez, Wei-Tang Kao, Braxton D. Mitchell, Alan R. Shuldiner, Laura M. Yerges‐Armstrong, Ingrid B. Borecki, J. Jeffrey Carr, Mary F. Feitosa, Jun Wu, Johannah L. Butler, Caroline S. Fox, Joel N. Hirschhorn, Udo Hoffmann, Shih‐Jen Hwang, Joseph M. Massaro, Christopher J. O’Donnell, Cameron D. Palmer, Dushyant V. Sahani, Elizabeth K. Speliotes, Xiuqing Guo, Jochen Hampe, Matthew Hickman, Lena Heintz, Christian Hudert, Harriet Hunter, Matt Kelly, Julia Kozlitina, Marcin Krawczyk, Frank Lammert, Claudia Langenberg, Joel E. Lavine, Lin Li, Hong Kai Lim, Rohit Loomba, Panu K. Luukkonen, Phillip E. Melton, Trevor A. Mori, Nicholette D. Palmer, Constantinos A. Parisinos, Sreekumar Pillai, Faiza Qayyum, Matthias Reichert, Stefano Romeo, Jerome I. Rotter, Yu Ri Im, Nicola Santoro, Clemens Schafmayer, Elizabeth K. Speliotes, Stefan Stender, Felix Stickel, Christopher D. Still, Pavel Strnad, Kent D. Taylor, Anne Tybjærg‐Hansen, Giuseppina Rosaria Umano and 10 more - Journal of Hepatology 2020 cited by 137

  23. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis

    Authors: , , , , , , , , , , , , , , - Gastroenterology 2017 cited by 269

  24. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , - JAMA Pediatrics 2016 cited by 221